Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05021_nanopub.RAH_2EbdW5MOsoK9iSTdJEbvMFn3Fj95vsoSX0IrQruhM#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05021 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05021 label "EMZ702 [drugbank:DB05021]" assertion.
- drugbank:DB05021 seeAlso DB05021 assertion.
- drugbank:DB05021 description "EMZ702, a non-toxic agent that has strong anti-viral synergy with interferon, is an ideal candidate for combination with current standard hepatitis C treatments. EMZ702 has an excellent safety profile and the combination of EMZ702 with interferon and ribavirin in surrogate models for hepatitis C has demonstrated a two to three fold increase in anti-viral potency compared to interferon and ribavirin alone." assertion.
- drugbank:DB05021 identifier "drugbank:DB05021" assertion.
- drugbank:DB05021 title "EMZ702" assertion.
- drugbank:DB05021 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05021 drugbank_vocabulary:drugbank-id "DB05021" assertion.
- drugbank:DB05021 bio2rdf_vocabulary:x-identifiers.org DB05021 assertion.
- drugbank:DB05021 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05021" assertion.
- drugbank:DB05021 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05021 bio2rdf_vocabulary:identifier "DB05021" assertion.